Prognostic markers which could support a more individualized anti-OC therapy are scarce.
Most importantly, it has been shown that CTCs could express epithelial-mesenchymal transition and/or cancer stem cell markers, which would support the hypothesis derived from the clinical data that CTCs are closely associated with distant metastasis in breast cancer patients [ 5].
This observation disagrees with current morphological classification and with phylogenetic reconstructions based on nuclear markers, which strongly support a monophyletic Anthozoa comprised of the Octocorallia and Hexacorallia (France et al. 1996; Odorico and Miller 1997; Berntson et al. 1999; Won et al. 2001; Collins 2002; Daly et al. 2007).
Our formulation takes that into consideration and uses only markers which have sufficient support to infer the presence of CYP2D7 (e.g. insertion of T at loci 137 indicates with high probability that CYP2D7 region is present).
High Glycine levels were found in HER-2pos tumors, which support Glycine as potential marker for tumor aggressiveness.
Satellite tracking studies of whale sharks have demonstrated both short and long range migratory movements, which support the gene flow inferred with microsatellite markers.
However, this genetic structuring was not supported by nuclear markers, which did not show any clear sign of population differentiation among islands.
Yoshimoto and coworkers [ 48] reported that histologic grade and clinical stage, including lymph node metastasis, are important prognostic markers in breast cancer patients, which supports the notion that the downregulation of APC7 can be a viable prognostic marker.
The relation between aR and health and personality markers can also be demonstrated, which supported Steiner's idea that a strong regulation has an impact on health and on personality markers [ 14, 15].
We showed that NAT1 protein expression was a prognostic marker in breast cancer patients, which supports previous reports by other groups.
